Spotlight on PreHistin in new ad campaign
IRVINE, Calif. — Cobalis on Tuesday began airing 60-second television commercials in support of its PreHistin allergy defense formula across national cable and satellite networks as part of a planned $5 million spend, the company announced.
“We are excited to announce the start of our national TV campaign for PreHistin, which was selected as Best New Product of 2011 out of a field of over a thousand products at the recent ECRM Cough, Cold and Allergy show,” Cobalis CEO Marty Marion said. “We are committed to supporting those retailers and pharmacies who are selling PreHistin, and television is just one of the support channels we are engaging to drive traffic, stimulate brand awareness and increase sales.“
The commercials were created to help build the PreHistin brand to consumers and allergy sufferers. The spots present the PreHistin story and prompt viewers that PreHistin now is available at pharmacies, and to “ask your pharmacist for PreHistin today.”
FDA: Dietary supplements distributed bear close resemblance to popular antibiotic
TUCKER, Ga. — A recent Food and Drug Administration inspection prompted the recall of dietary supplements distributed by Multi-Mex Distributor, the company announced Monday. According to an FDA post, the supplements in question bore a close resemblance to antibiotics available in Mexico and may have been confusing to Hispanic consumers.
Warnings of these dietary supplements made news in Texas on April 28, when four children were taken to a medical center due to worsening illnesses after being given dietary supplements that their parents may have believed were antibiotics. Giving the dietary supplement delayed legitimate medical treatment, the FDA reported.
“Although the labels were printed in English and Spanish, the packaging appears to be an intentional marketing ploy to mimic antibiotics and directed at Hispanic buyers,” the agency stated. “It was determined the children had been given a dietary supplement, Amoxilina, which the parents may have believed was the antibiotic amoxicillin.”
The products were distributed in the following states: Georgia, Tennessee, California, Illinois, Texas, North Carolina, South Carolina, Colorado and Indianapolis.
For a listing of the universal product codes, click here.
Missouri’s Rx-only PSE legislation moves to state Senate
ST. LOUIS — Missouri’s House of Representatives on Monday voted 100 in favor and 50 opposed to reclassifying pseudoephedrine as a prescription-only remedy and subsequently moved the matter to the state Senate — this despite the fact that electronic track-and-trace has been up and running for the past six months, blocking more than 30,000 potentially illegal PSE purchases, stated Scott Melville, president and CEO of the Consumer Healthcare Products Association.
"Moving forward, our hope is that the state senators apply common sense leadership and stop prescription-only legislation that would hurt Missourians, while standing up for electronic tracking technology, which we already know is working to stop those seeking to illegally purchase pseudoephedrine-containing medicines,” Melville said.
A recent national survey of more than 2,000 asthma, allergy, cold and flu patients conducted by the Asthma and Allergy Foundation of America with the Harris Interactive research organization showed an overwhelming majority of patients (71%) oppose laws that would require a doctor’s prescription for PSE-containing medicines. As many as two-thirds of those patients supported an e-tracking system.